Graphical presentation of % decrease for insulin from baseline at different conditions. by Nathan Mubiru (21627195)

Graphical presentation of % decrease for C-peptide from baseline at different conditions. by Nathan Mubiru (21627195)

Loss of FAT1 expression results in increased YAP/TAZ protein levels. by Rui Li (4631)

Distribution of KTAS levels and outcomes in the study population by age. by Hun Gi Lee (21526538)

Role of MIB2 and CAMK2 in FAT1-depndent regulation of YAP/TAZ protein levels and YAP/TAZ nuclear localization. by Rui Li (4631)

Role of MIB2 in tumor cell growth <i>in vitro.</i> by Rui Li (4631)

Regulation of YAP/TAZ through MIB2 in HNSCCs. by Rui Li (4631)

Role of YAP/TAZ in FAT1-regulated HNSCC growth. by Rui Li (4631)

FAT1 and MIB2 control tumor growth <i>in vivo.</i> by Rui Li (4631)

FAT1 interacts with the E3 ligase MIB2. by Rui Li (4631)

Gene expression levels of <i>CB1R</i>, <i>CB2R</i>, and <i>MAGL</i> in KA-injected mice treated with compound 4f. by Naoto Arimura (416442)

Subjects:

Dynamics of cortisol levels measured in pregnant women during pregnancy determined at different ANC visits. by Francois Kiemde (5369657)

“…In both group, cortisol concentration increased in a sawtooth pattern during pregnancy with peaks at V2(28^th±1 week) and V4 32^th ±1 week), before decreasing at V5 which is part of post-partum.…”

IQGAP1 is a protein that plays a critical role in regulating the level of apoptosis in endothelial cells. by Shaojun Huang (12489901)

Target miRNA information. by Mísia Helena da Silva Ferro (20623666)

“…Although the data suggest an alteration (increase or decrease depending on the region and microRNA) of expression levels of some microRNAs in the brain and cerebellum of pinealectomized rats, the differences were not statistically significant. …”

Effects of compound 4f on neuroinflammation in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

Top 20 IPA pathways of 2405 genes downregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Subjects:

All data in the manuscript and supporting information. by Naoto Arimura (416442)

Subjects:

The effects of cannabinoid receptor antagonists against neuroprotective effects of compound 4f in KA-treated mice. by Naoto Arimura (416442)

Subjects:

Representative image data in Fig 5. by Naoto Arimura (416442)

Subjects:

Pharmacokinetics and pharmacodynamics of compound 4f in mice. by Naoto Arimura (416442)

Subjects: